Valdepharm SA
Valdepharm SA, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe. Founded in 1998, the company has established itself as a leader in the development and manufacturing of high-quality sterile injectable products, particularly for the oncology and critical care sectors. Valdepharm's commitment to innovation is evident in its state-of-the-art facilities, which adhere to the highest regulatory standards. The company’s core offerings include a range of injectable medications that are distinguished by their rigorous quality control processes and advanced production techniques. With a strong market position, Valdepharm SA has achieved significant milestones, including successful partnerships with major pharmaceutical companies and a growing portfolio of proprietary products. This dedication to excellence has solidified its reputation as a trusted provider in the global healthcare landscape.
DitchCarbon Score
How does Valdepharm SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Valdepharm SA's score of 28 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Valdepharm SA's reported carbon emissions
Valdepharm SA, headquartered in France, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is important to note that Valdepharm SA has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of publicly available information on climate commitments may reflect a broader industry context where companies are increasingly being urged to disclose their environmental impact and set ambitious sustainability goals. As the global focus on climate change intensifies, it is essential for companies like Valdepharm SA to establish clear climate commitments and reduction strategies to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Valdepharm SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
